ArticleCase reports in rheumatology2018

Increasing the Interval of Canakinumab Administration Effectively Supports the Remission of Schnitzler's Syndrome.

Vadim R Gorodetskiy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.